Merck & Co., Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Merck & Co., Inc.
CIK #0000310158
Sector Form 13F Holdings Value ($M)
Personalis Inc 92.1
Moderna Inc 63.7
Kymera Therapeutics Inc 33.7
Alector Inc 5.0
Evaxion Biotech A/S 3.0
Sutro Biopharma Inc 1.9
LAVA Therapeutics NV 1.5
Signal Genetics Inc 1.3
Xilio Therapeutics Inc 1.0
Eleven Biotherapeutics Inc 0.6
View All
Holdings by Sector ($M)
2502001501005002024202420252026
EDGAR Form CIK 2011 - 2025
10-K [0000310158]
10-Q [0000310158]
13F-HR [0000310158]
3 [0000310158]
4 [0000310158]
5 [0000310158]
8-K [0000310158]
SC 13D [0000310158]
SC 13G [0000310158]
Form 13D/13G Filer Form 13D/13G Subject Filed
Merck & Co Inc Personalis Inc [2024-12-23]
Merck & Co Inc Evaxion Biotech A/S [2024-01-23]
Merck & Co Inc 4D Pharma PLC [2022-02-02]
Merck & Co Inc Pandion Therapeutics Inc [2021-03-04]
Merck & Co Inc Yumanity Therapeutics Inc [2021-01-04]
Merck & Co Inc Arqule Inc [2019-12-16]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Merck & Co Inc Alector Inc [2019-02-14]
Merck & Co Inc Sutro Biopharma Inc [2018-10-04]
Merck & Co Inc Menlo Therapeutics Inc [2018-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Merck & Co., Inc.
Guindo Chirfi
Williams David Michael
Coe Mary Ellen
Glocer Thomas H
Seidman Christine E
Craig Pamela J.
Lavizzo-Mourey RISA J
Karsanbhai Surendralal Lanca
Baker Douglas M Jr
Warden Kathy J
Thulin Inge G
Russo Patricia F
Rothman Paul
Mayo Stephen
Smart Dalton E. III
Larson Betty D
Romanelli Joseph
Oosthuizen Johannes Jacobus
Chattopadhyay Sanat
DeLuca Richard R.
Davis Robert M
Li Dean Y
Zachary Jennifer
Downing Cristal N
Litchfield Caroline
Merck Sharp & Dohme LLC
Personalis, Inc.
Klobuchar Michael A
Wendell Peter C
Harpoon Therapeutics, Inc.
Mizell Steven
LeCointe-Cephas Lisa
Karachun Rita A
Frazier Kenneth C
Garay Arpa
Gerberding Julie L.
Clyburn Frank
Organon & Co.
Brun Leslie A
Pandion Therapeutics, Inc.
Nally Michael
Fleming Michael
Cech Thomas R
Weeks Wendell P
Perlmutter Roger M
Lazarus Rochelle B
Merck Sharp & Dohme Corp.
Arqule Inc
Scholefield James H
NGM Biopharmaceuticals Inc
Noseworthy John H
Schechter Adam H
Watson Ashley
Sutro Biopharma Inc
Thompson Craig B.
Graddick Weir Mirian M
Holston Michael J
Opgen Inc
Merck Global Health Innovation Fund, LLC
VYNE Therapeutics Inc.
Represas Carlos E
Kidder C Robert
Ambrose Adele D
Golestani Clark
Rosenblatt Michael
Harrison William B Jr
Deese Willie A
BeOne Medicines Ltd.
Merck Sharp & Dohme Research GmbH
Kuhlik Bruce N
Heller Bridgette P
Canan John
Kellogg Peter N
Do Cuong V
Kim Peter S
Bowles Richard S III
Scalet J Chris
Tatlock Anne M
Kelley Willam N
Goldstone Steven F
Kohan Raul E
Terms | Privacy | Guide
tony@aum13f.com